Patents by Inventor Doris KIM

Doris KIM has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • THERAPEUTIC, DIAGNOSTIC, AND PROGNOSTIC METHODS FOR CANCER
    Publication number: 20230220491
    Abstract: The invention provides methods and compositions to detect expression of one or more biomarkers, including FGFR3, TP53, and/or EGFR, for treating, diagnosing, and providing a prognosis for cancer, e.g., bladder cancer. The invention also provides kits and articles of manufacture for use in the methods.
    Type: Application
    Filed: January 20, 2023
    Publication date: July 13, 2023
    Inventors: YounJeong CHOI, Omar Kabbarah, Doris Kim
  • ANTI-PD-L1 ANTIBODIES AND METHODS OF USING THE SAME FOR DETECTION OF PD-L1
    Publication number: 20230052312
    Abstract: The present application relates to anti-PD-L1 antibodies and their use to detect PD-L1 in a sample from a subject. In some embodiments, the subject has been treated with a therapeutic anti-PD-L1 antibody and an anti-PD-L1 described herein does not compete for binding to PD-L1 with the therapeutic anti-PD-L1 antibody. In some embodiments, the anti-PD-L1 antibody is linked to a detectable moiety, such as a fluorophore and the anti-PD-L1 antibody is used to detect PD-L1 in a subject using flow cytometry.
    Type: Application
    Filed: February 16, 2022
    Publication date: February 16, 2023
    Applicant: Genentech, Inc.
    Inventors: Doris KIM, Terence Wong, Anan Chuntharapai, Cherie Louise Green
  • THERAPEUTIC, DIAGNOSTIC, AND PROGNOSTIC METHODS FOR CANCER
    Publication number: 20220267864
    Abstract: The invention provides methods and compositions to detect expression of one or more biomarkers, including FGFR3, TP53, and/or EGFR, for treating, diagnosing, and providing a prognosis for cancer, e.g., bladder cancer. The invention also provides kits and articles of manufacture for use in the methods.
    Type: Application
    Filed: May 12, 2022
    Publication date: August 25, 2022
    Inventors: YounJeong CHOI, Omar KABBARAH, Doris KIM
  • Anti-PD-L1 antibodies and methods of using the same for detection of PD-L1
    Patent number: 11292843
    Abstract: The present application relates to anti-PD-L1 antibodies and their use to detect PD-L1 in a sample from a subject. In some embodiments, the subject has been treated with a therapeutic anti-PD-L1 antibody and an anti-PD-L1 described herein does not compete for binding to PD-L1 with the therapeutic anti-PD-L1 antibody. In some embodiments, the anti-PD-L1 antibody is linked to a N detectable moiety, such as a fluorophore and the anti-PD-L1 antibody is used to detect PD-L1 in a subject using flow cytometry.
    Type: Grant
    Filed: May 27, 2020
    Date of Patent: April 5, 2022
    Assignee: Genentech, Inc.
    Inventors: Doris Kim, Terence Wong, Anan Chuntharapai, Cherie Louise Green
  • ANTI-PD-L1 ANTIBODIES AND METHODS OF USING THE SAME FOR DETECTION OF PD-L1
    Publication number: 20200291119
    Abstract: The present application relates to anti-PD-L1 antibodies and their use to detect PD-L1 in a sample from a subject. In some embodiments, the subject has been treated with a therapeutic anti-PD-L1 antibody and an anti-PD-L1 described herein does not compete for binding to PD-L1 with the therapeutic anti-PD-L1 antibody. In some embodiments, the anti-PD-L1 antibody is linked to a N detectable moiety, such as a fluorophore and the anti-PD-L1 antibody is used to detect PD-L1 in a subject using flow cytometry.
    Type: Application
    Filed: May 27, 2020
    Publication date: September 17, 2020
    Applicant: Genentech, Inc.
    Inventors: Doris KIM, Terence WONG, Anan CHUNTHARAPAI, Cherie Louise GREEN
  • THERAPEUTIC, DIAGNOSTIC, AND PROGNOSTIC METHODS FOR CANCER
    Publication number: 20170306418
    Abstract: The invention provides methods and compositions to detect expression of one or more biornarkers, including FGFR3, TP53, and/or EGFR, for treating, diagnosing, and providing a prognosis for cancer, e.g., bladder cancer. The invention also provides kits and articles of manufacture for use in the methods.
    Type: Application
    Filed: June 21, 2017
    Publication date: October 26, 2017
    Inventors: YounJeong CHOI, Omar KABBARAH, Doris KIM